GlassScriptPhysician profile
Arthur W Black
NPI 1639497324
$3,654.33
in general payments reported to CMS, 2019-2025
31 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $320 · 2021: $338 · 2022: $370 · 2023: $927 · 2024: $621 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $620.54 | 2019-2025 | Puraply Antimicrobial, Affinity, Simplimax |
| Stryker Corporation | $461.20 | 2022-2025 | Citrefix |
| Horizon Therapeutics Plc | $393.30 | 2019-2022 | |
| Integra Lifesciences Corporation | $194.68 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $190.80 | 2019-2020 | |
| Djo, LLC | $189.70 | 2023 | Aircast, Donjoy, Procare |
| Smith+Nephew, INC. | $180.46 | 2019-2025 | Grafix Pl |
| Zimmer Biomet Holdings, INC. | $156.14 | 2019-2023 | Affixus |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $135.34 | 2020-2024 | Jublia |
| Averitas Pharma INC. | $129.22 | 2024 | Qutenza |
| Pfizer INC. | $126.97 | 2019 | |
| Convatec INC. | $120.41 | 2023 | |
| Linvatec Corporation | $109.81 | 2023 | Allograft Tissue |
| Medtronic, INC. | $88.22 | 2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $70.23 | 2023-2025 | Zilretta, Exparel |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $64.45 | 2019-2020 | |
| Kerecis Limited | $54.92 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acumed LLC | $48.50 | 2024 | Acumed, Osteomed |
| Fidia Pharma USA INC. | $44.81 | 2022-2024 | Hymovis, Hyalgan, Triluron |
| Kci USA, INC. | $31.82 | 2019 | |
| Cashflow Solutions, LLC | $30.86 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Abbott Laboratories | $27.22 | 2019 | |
| Heron Therapeutics, INC. | $26.22 | 2022 | |
| Abbvie INC. | $25.37 | 2023 | Dalvance |
| Depuy Synthes Sales INC. | $25.18 | 2023 | Va-Lcp |
| Ibsa Pharma INC. | $24.30 | 2023 | Tirosint, Licart |
| Triad Life Sciences INC. | $23.89 | 2022 | |
| Bioventus LLC | $19.69 | 2019 | |
| Curonix LLC | $15.27 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Progenacare Global, LLC | $13.70 | 2024 | |
| Next Science LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.